Drugs / PLANTAGO SEED

Trials 2

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 41 trial
Phase 4 NCT03670043 Mar 2019 → Oct 2020 type 2 diabetes mellitus West Side Institute for Science and Education Completed No outcome recorded
Phase not applicable1 trial · 1 met primary
— NCT00189033 Apr 2005 → Apr 2007 functional colonic disease UMC Utrecht Completed Met primary
Comparator or background therapy3 trials
Phase 2 NCT06639984 Comparator Feb 2025 → Sep 2027 expected irritable bowel syndrome Dr Bruno Chumpitazi, M.D. Recruiting No outcome recorded
Phase 2 NCT02144753 Comparator Mar 2014 → Apr 2016 irritable bowel syndrome Nutrabiotix, LLC Terminated No outcome recorded
Phase 2/3 NCT06166615 Comparator Dec 2023 → May 2024 — Seoul National University Hospital Unknown No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 6 sources stand behind the page.

FieldValueCited text
Known as PLANTAGO SEED ChEMBL registry synonym — accepted as the source's own label CHEMBL2108130 ↗
Known as Agio “Psyllium (Agio®) for the Treatment of Fecal Incontinence” NCT06166615 ↗
Known as Plantago afra l. seed ChEMBL registry synonym — accepted as the source's own label CHEMBL2108130 ↗
Known as Plantago indica l. seed ChEMBL registry synonym — accepted as the source's own label CHEMBL2108130 ↗
Known as Plantago seed, unspecified ChEMBL registry synonym — accepted as the source's own label CHEMBL2108130 ↗
Known as Psyllii semen ChEMBL registry synonym — accepted as the source's own label CHEMBL2108130 ↗
Known as Psyllium ClinicalTrials.gov intervention name — accepted as the source's own label NCT06639984 ↗
4

NCT03670043 ↗

NCT02144753 ↗

NCT06166615 ↗

NCT00189033 ↗

Modality Other / unclassified “prebiotic fiber Psyllium will ameliorate diarrhea” NCT03670043 ↗
Route Oral “Take 2 sachets (12 g) orally once daily.” NCT06166615 ↗